Chemed Corp (CHE)

Chemed currently trades at $601.30 per share and has shown little upside over the past six months, posting a middling return of 2.7%. However, the stock is beating the S&P 500’s 3.3% decline during that period.

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the senior health, home health & hospice industry, including Brookdale (NYSE:BKD) and its peers.

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns - over the past six months, healthcare stocks have collectively shed 9.4%. This performance was disappointing since the S&P 500 held its ground.

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the senior health, home health & hospice industry, including AdaptHealth (NASDAQ:AHCO) and its peers.

Healthcare services company Chemed Corporation (NYSE:CHE) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 9.2% year on year to $640 million. Its non-GAAP profit of $6.83 per share was 0.7% above analysts’ consensus estimates.

Healthcare services company Chemed Corporation (NYSE:CHE) will be reporting results tomorrow after market hours. Here’s what to expect.

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how AdaptHealth (NASDAQ:AHCO) and the rest of the senior health, home health & hospice stocks fared in Q3.

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Brookdale (NYSE:BKD) and its peers.

Looking back on senior health, home health & hospice stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Chemed (NYSE:CHE) and its peers.

Let’s dig into the relative performance of The Pennant Group (NASDAQ:PNTG) and its peers as we unravel the now-completed Q3 senior health, home health & hospice earnings season.

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Option Care Health (NASDAQ:OPCH) and its peers.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at senior health, home health & hospice stocks, starting with BrightSpring Health Services (NASDAQ:BTSG).

As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the senior health, home health & hospice industry, including Addus HomeCare (NASDAQ:ADUS) and its peers.